| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Association of IASLC/ATS/ERS Histologic Subtypes of Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutations in 320 Resected Cases
|
Nakamura, Haruhiko
|
|
2015
|
16 |
3 |
p. 209-215
7 p.
|
artikel
|
| 2 |
Bridging Tumor Genomics to Patient Outcomes Through an Integrated Patient-Derived Xenograft Platform
|
Gandara, David R.
|
|
2015
|
16 |
3 |
p. 165-172
8 p.
|
artikel
|
| 3 |
Correlation of Dosimetric and Clinical Factors With the Development of Esophagitis and Radiation Pneumonitis in Patients With Limited-Stage Small-Cell Lung Carcinoma
|
Giuliani, Meredith E.
|
|
2015
|
16 |
3 |
p. 216-220
5 p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
2015
|
16 |
3 |
p. A6-
1 p.
|
artikel
|
| 5 |
Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non–Small-Cell Lung Cancer
|
Reynolds, Craig H.
|
|
2015
|
16 |
3 |
p. 200-208
9 p.
|
artikel
|
| 6 |
How Do Elderly Poor Prognosis Patients Tolerate Palliative Concurrent Chemoradiotherapy for Locally Advanced Non–Small-Cell Lung Cancer Stage III? A Subset Analysis From a Clinical Phase III Trial
|
Strøm, Hans H.
|
|
2015
|
16 |
3 |
p. 183-192
10 p.
|
artikel
|
| 7 |
Intensity-Modulated Proton Therapy for Elective Nodal Irradiation and Involved-Field Radiation in the Definitive Treatment of Locally Advanced Non–Small-Cell Lung Cancer: A Dosimetric Study
|
Kesarwala, Aparna H.
|
|
2015
|
16 |
3 |
p. 237-244
8 p.
|
artikel
|
| 8 |
Intercalated Dosing Schedule of Erlotinib and Docetaxel as a Therapeutic Strategy to Avoid Antagonism and Optimize Its Benefits in Advanced Non–Small-Cell Lung Cancer. A Randomized Phase II Clinical Trial
|
Juan, Óscar
|
|
2015
|
16 |
3 |
p. 193-199
7 p.
|
artikel
|
| 9 |
Response to Cytotoxic Chemotherapy in Patients Previously Treated With Palliative-Intent Chemotherapy for Advanced Thymic Carcinoma
|
Okuma, Yusuke
|
|
2015
|
16 |
3 |
p. 221-227
7 p.
|
artikel
|
| 10 |
Should Tyrosine Kinase Inhibitors Be Considered for Advanced Non–Small-Cell Lung Cancer Patients With Wild Type EGFR? Two Systematic Reviews and Meta-Analyses of Randomized Trials
|
Vale, Claire L.
|
|
2015
|
16 |
3 |
p. 173-182.e4
1.819828E6 p.
|
artikel
|
| 11 |
Survival Outcome Assessed According to Tumor Burden and Progression Patterns in Patients With Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Undergoing Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy
|
Cha, Yoon Ki
|
|
2015
|
16 |
3 |
p. 228-236
9 p.
|
artikel
|
| 12 |
Table of Contents
|
|
|
2015
|
16 |
3 |
p. A11-A12
nvt p.
|
artikel
|
Tijdschrift beschrijving